TUSSIGON Drug Patent Profile
When do Tussigon patents expire, and what generic alternatives are available?
Tussigon is a drug marketed by King Pharms and is included in one NDA.
The generic ingredient in TUSSIGON is homatropine methylbromide; hydrocodone bitartrate. There is one drug master file entry for this compound. Five suppliers are listed for this compound. Additional details are available on the homatropine methylbromide; hydrocodone bitartrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tussigon
A generic version of TUSSIGON was approved as homatropine methylbromide; hydrocodone bitartrate by AVANTHI INC on August 7th, 2017.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TUSSIGON?
- What are the global sales for TUSSIGON?
- What is Average Wholesale Price for TUSSIGON?
Summary for TUSSIGON
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Patent Applications: | 4 |
| Drug Prices: | Drug price information for TUSSIGON |
| DailyMed Link: | TUSSIGON at DailyMed |
US Patents and Regulatory Information for TUSSIGON
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| King Pharms | TUSSIGON | homatropine methylbromide; hydrocodone bitartrate | TABLET;ORAL | 088508-001 | Jul 30, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
